Article Information
| Title: | Discussing Sentinel Lymph Node Biopsy With Your Melanoma Patients |
| Author: | Brooke T. Baldwin MD, Basil S. Cherpelis MD, Neil Alan Fenske MD |
| Abstract: | Sentinel lymph node biopsy, indicated for stage 1B/2 melanoma may be an underutilized diagnostic modality. Experts in the field agree that sentinel lymph node biopsy should be offered to patients with T1 melanomas with primary tumor ulceration, a mitotic rate greater than or equal to 1/mm2, and/or Clark level IV/V invasion especially if tumor thickness exceeds 0.75 mm. It is the responsibility of practitioners to characterize patients as eligible or non-eligible for the sentinel node procedure. Furthermore, it is important to obtain a fully informed consent and explain to patients the statistics of the progonostic information garnered by the test. |
| Section: | Original Article |
| Year: | 2010 |
| Volume: | 9 |
| Issue: | 7 |
| Page: | 790 |
|
Journal
Library
Subscription
Submissions
Information
Home | Privacy Policy | Terms & Conditions | Contact Us
377 Park Avenue South, 6th Floor, New York, NY 10016
Phone: (212) 213-5434 Fax: (212) 213-5435
Copyright © 2009 - Journal of Drugs in Dermatology
